Early experience with small volume periurethral polytetrafluoroethylene for female stress urinary incontinence

被引:20
作者
Herschorn, S [1 ]
Glazer, AA [1 ]
机构
[1] Univ Toronto, Sunnybrook & Womens Hlth Sci Ctr, Dept Surg, Div Urol, Toronto, ON, Canada
关键词
polytetrafluoroethylene; injections; urinary incontinence; stress; urethra;
D O I
10.1016/S0022-5347(05)67555-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Injectable polytetrafluoroethylene paste has been used to treat female stress urinary incontinence. Since the substance is antigenically nonreactive we postulated that the reported morbidity may be due in part to the relatively large volumes injected. Therefore, we assessed the outcome of injecting small volumes of polytetrafluoroethylene with attention to the durability of success and morbidity. Materials and Methods: A total of 46 women with a median age of 73.8 years (range 26 to 88) with stress urinary incontinence were treated. The procedure was done on an outpatient basis using topical urethral lidocaine and periurethral lidocaine as anesthesia. A 20Fr urethroscope was used to inject polytetrafluoroethylene through an 18 gauge needle periurethrally, Patients were reinjected 1 to 3 months after initial injection if not cured (no incontinence or no pads). Continence was assessed by questionnaire from an interviewer not known to the patient. Subsequent top-up injections were given if required. Morbidity was monitored with clinical examination and imaging as required. Results: Of the patients 14 (30.4%) were dry, 19 (41.3%) were improved and 13 (28.3%) had treatment failure at a mean of 17.9, 15.9 and 9.1 months, respectively, after last injection. For cured and improved patients (71.7%) an average of 2 treatments were needed, for a total mean volume of 5.4 cc polytetrafluoroethylene. Using a Kaplan-Meier survival curve the probability of the 14 patients remaining dry without additional polytetrafluoroethylene was 90% at 1 and 60% at 2 years. Outcome was not affected by radiological type of incontinence (that is with or without hypermobility), age, pretreatment bladder instability or previous interventions. Conclusions: Periurethral injection of small volumes of polytetrafluoroethylene is effective and safe for treatment of female stress urinary incontinence. Early analysis shows that success is durable with minimal morbidity.
引用
收藏
页码:1838 / 1842
页数:5
相关论文
共 27 条
[1]  
APPELL RA, 1998, CAMPBELLS UROLOGY, V1, P1109
[2]  
ARNOLD GE, 1962, ARCHIV OTOLARYNGOL, V76, P358
[3]   LONG-TERM FOLLOW-UP OF WOMEN TREATED WITH PERURETHRAL TEFLON INJECTIONS FOR STRESS-INCONTINENCE [J].
BECKINGHAM, IJ ;
WEMYSSHOLDEN, G ;
LAWRENCE, WT .
BRITISH JOURNAL OF UROLOGY, 1992, 69 (06) :580-583
[4]  
BERG S, 1973, ARCH SURG-CHICAGO, V107, P379
[5]  
BLAIVAS JG, 1987, AUA UPDATE SERIES, V6
[6]  
Canning D. A., 1988, J UROLOGY, V139, P258
[7]  
CLAES H, 1989, J UROLOGY, V142, P821
[8]  
FORD CN, 1986, LARYNGOSCOPE, V96, P1248
[9]  
GANGAL SV, 1980, ENCY CHEM TECHNOLOGY, V2, P1
[10]   PERIURETHRAL TEFLON FOR STRESS URINARY-INCONTINENCE - MEDIUM-TERM RESULTS [J].
HARRISON, SCW ;
BROWN, C ;
OBOYLE, PJ .
BRITISH JOURNAL OF UROLOGY, 1993, 71 (01) :25-27